{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:03:37Z","timestamp":1776913417269,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T00:00:00Z","timestamp":1465948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1136\/annrheumdis-2016-209285","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T06:01:56Z","timestamp":1466056916000},"page":"386-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"title":["Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers"],"prefix":"10.1016","volume":"76","author":[{"given":"Louise K","family":"Mercer","sequence":"first","affiliation":[]},{"given":"Johan","family":"Askling","sequence":"additional","affiliation":[]},{"given":"Pauline","family":"Raaschou","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5881-4857","authenticated-orcid":false,"given":"William G","family":"Dixon","sequence":"additional","affiliation":[]},{"given":"Lene","family":"Dreyer","sequence":"additional","affiliation":[]},{"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[]},{"given":"Anja","family":"Strangfeld","sequence":"additional","affiliation":[]},{"given":"Angela","family":"Zink","sequence":"additional","affiliation":[]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[]},{"given":"Axel","family":"Finckh","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Canhao","sequence":"additional","affiliation":[]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[]},{"given":"Jakub","family":"Zavada","sequence":"additional","affiliation":[]},{"given":"Jacques","family":"Morel","sequence":"additional","affiliation":[]},{"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-9262","authenticated-orcid":false,"given":"Kimme L","family":"Hyrich","sequence":"additional","affiliation":[]},{"given":"Joachim","family":"Listing","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2016-209285_bib1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1136\/annrheumdis-2016-209285_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.27616","article-title":"International trends in the incidence of malignant melanoma 1953\u20132008\u2013are recent generations at higher or lower risk?","volume":"132","author":"Erdmann","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1136\/annrheumdis-2016-209285_bib3","doi-asserted-by":"crossref","first-page":"e95096","DOI":"10.1371\/journal.pone.0095096","article-title":"Risk of melanoma in people with HIV\/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies","volume":"9","author":"Olsen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1136\/annrheumdis-2016-209285_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2016-209285_bib5","doi-asserted-by":"crossref","first-page":"f1939","DOI":"10.1136\/bmj.f1939","article-title":"Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden","volume":"346","author":"Raaschou","year":"2013","journal-title":"BMJ"},{"key":"10.1136\/annrheumdis-2016-209285_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","article-title":"Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population","volume":"52","author":"Mercer","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209285_bib7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","volume":"32A","author":"Mellemkjaer","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1136\/annrheumdis-2016-209285_bib8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.23716","article-title":"Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate","volume":"59","author":"Buchbinder","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209285_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","article-title":"Incidence of cancer among patients with rheumatoid arthritis","volume":"85","author":"Gridley","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/annrheumdis-2016-209285_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"88","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1136\/annrheumdis-2016-209285_bib11","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","article-title":"Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209285_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2012-201969","article-title":"Incidences of overall and site specific cancers in TNFalpha inhibitor treated patients with rheumatoid arthritis and other arthritides\u2014a follow-up study from the DANBIO Registry","volume":"72","author":"Dreyer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209285_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/cyto.1999.0614","article-title":"Autocrine and paracrine regulation by cytokines and growth factors in melanoma","volume":"12","author":"Lazar-Molnar","year":"2000","journal-title":"Cytokine"},{"key":"10.1136\/annrheumdis-2016-209285_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00432-010-0900-1","article-title":"Serum TNF-alpha, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-alpha2b treatment of patients with melanoma","volume":"137","author":"Hofmann","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1136\/annrheumdis-2016-209285_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<202::AID-SSU3>3.0.CO;2-C","article-title":"Isolated limb perfusion in primary and recurrent melanoma: indications and results","volume":"14","author":"Li\u00e9nard","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1136\/annrheumdis-2016-209285_bib16","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/art.24941","article-title":"Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?","volume":"60","author":"Askling","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209285_bib17","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar2904","article-title":"Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT","volume":"12","author":"Strangfeld","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-209285_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.091025","article-title":"The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events","volume":"68","author":"Leombruno","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209285_bib19","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Mariette","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209285_bib20","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1136\/annrheumdis-2016-209285_bib21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/annrheumdis-2011-200622","article-title":"The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register","volume":"71","author":"Mercer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209285_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/keq368","article-title":"Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries","volume":"50","author":"Mariette","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209285_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ard.2005.045872","article-title":"Swedish registers to examine drug safety and clinical issues in RA","volume":"65","author":"Askling","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209285_bib24","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/art.22808","article-title":"Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209285_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/rheumatology\/keq309","article-title":"DANBIO\u2013\u2212powerful research database and electronic patient record","volume":"50","author":"Hetland","year":"2011","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2016-209285_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/biostatistics\/5.1.61","article-title":"A comparison of non-iterative and iterative estimators of heterogeneity variance for the standardized mortality ratio","volume":"5","author":"B\u00f6hning","year":"2004","journal-title":"Biostatistics"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724028656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724028656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2016-209285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:34:20Z","timestamp":1739522060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724028656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0003496724028656"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-209285","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-209285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/www.bmj.com\/company\/products-services\/rights-and-licensing. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}